Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound
Abstract
Objectives
Adipocyte fatty acid-binding protein (A-FABP) has been shown to have an effect on insulin resistance, lipid metabolism, and atherosclerosis in animals. We therefore investigated the association between the serum A-FABP level and coronary atherosclerosis.
Methods
One hundred twenty-five consecutive patients with coronary artery disease (CAD) were enrolled after coronary angiography. Plaque volume in non-culprit coronary arteries was determined using intravascular ultrasound and expressed as percent plaque volume (%PV). Voluntary blood donors (n
=
120), matched for age and gender, served as controls. Serum levels of A-FABP, adiponectin, and inflammatory markers were measured by enzyme-linked immunosorbent assay.
Results
The serum A-FABP level in CAD patients was significantly higher than in control subjects (median [25th–75th percentiles], 27.2 [20.5–37.1]
ng/mL vs. 18.9 [14.6–24.5]
ng/mL) (p
<
0.01). Serum A-FABP showed 0.74 of the area under the curve in the receiver operating characteristic curve for the detection of CAD, with 76% specificity and 65% sensitivity with a cut-off value of 20.1
ng/mL. Further, in CAD patients, serum A-FABP had a significant correlation with %PV in all subjects (r
=
0.33, p
<
0.01). Serum A-FABP was positively correlated with the body mass index, serum interleukin-6 and high-sensitive CRP, and negatively correlated with HDL-cholesterol and serum adiponectin in CAD patients. Stepwise regression analysis revealed that serum A-FABP was independently associated with %PV.
Conclusion
Increased serum A-FABP was significantly associated with a greater coronary plaque burden. Our findings revealed that the measurement of serum A-FABP could be utilized for the evaluation of the extent of coronary atherosclerosis.
Keywords: Adipocyte, Fatty acid-binding protein, Coronary artery disease, Intravascular ultrasound
To access this article, please choose from the options below
PII: S0021-9150(10)00080-8
doi:10.1016/j.atherosclerosis.2010.01.032
© 2010 Elsevier Ireland Ltd. All rights reserved.
